Viewing Study NCT05694728


Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2026-01-27 @ 4:40 AM
Study NCT ID: NCT05694728
Status: COMPLETED
Last Update Posted: 2023-01-23
First Post: 2022-12-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine
Sponsor: Beijing Health Guard Biotechnology, Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Human Papilloma Virus Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CIN View
None VIN View
None VaIN View
None AIN View
None Cervical cancer View
None Vulvar cancer View
None Anal cancer View
None Genital warts View